Surgical Management of Ulcerative ColitisB. Severe\ഠulcerative colitis. Mucosal ulceration and...
Transcript of Surgical Management of Ulcerative ColitisB. Severe\ഠulcerative colitis. Mucosal ulceration and...
Surgical Management of Ulcerative Colitis
Kiyanda BaldwinSUNY Downstate Grand Rounds
Kings County Hospital3/10/11
www.downstatesurgery.org
Patient Presentation 54 y/o M h/o UC x16yrs last c-scope low
grade dysplasia PMH UC PSH appendectomy All nkda Meds: prednisone, asacol, 6MP FH NC SH denies x3
www.downstatesurgery.org
H/H 12/36.8
Alb 3.9
CXR wnl
CT minimal thickening of ascending & descending colon w/ pericolonic lymphadenopathy consistent w/ chronic inflammation
UGI series WNL
C-scope pan colitis random Bx chronic inflam, cryptitis, low grade dysplasia
Patient Presentationwww.downstatesurgery.org
Ex-lap, proctocolectomy, double-staple ileal J pouch anal anastomosis, intraopcolonoscopy, diverting loop ileostomy
Path: pancolitis, low grade dysplasia
Now 1 month postop doing well
Patient Presentationwww.downstatesurgery.org
Surgical Management of
Ulcerative Colitis
www.downstatesurgery.org
Epiemiology Incidence: 8-15/100,000
Incidence lower in Asia, Africa, S. America,
& nonwhite Americans
Peaks in 3rd & 7th decades
Schwartz 9th ed, Maingot 11thed
www.downstatesurgery.org
Etiology Geographic differences suggest
environmental (diet/infection)
Smoking, etoh, OCPs implicated
Genetic? 10-30% have + FH
autoimmune
Schwartz 9th ed, Maingot 11th ed
www.downstatesurgery.org
Pathophysiology Poorly understood
Intestinal mucosa continually exposed to
environmental challenge
chronic dysregulation of mucosal immunity
uncontrolled inflammatory response
IL-1B, 6, 8, TNF, prostaglandin (E2), leukotriene B4
exacerbate mucosal inflammation
IL-4, 10 suppress intestinal inflammationMaingot 11thed
www.downstatesurgery.org
Sydney Australia; Neurogastroenterology Motility
Tachykinins, like substance P & neurokinin,
hemokinin
Role in motility, secretion, and immune functions
Tachykinin receptor gene expression was 10-fold
more abundant in colon mucosa of pts w/ UC
compared to Control (p<0.01)
Liu et al, Feb 2011www.downstatesurgery.org
Pathology Colonic mucosa & submucosa infiltrated w/
inflammatory cells
Mucosal edema is the earliest manifestation
Ulcers are linear & knifelike
Atrophic mucosa & crypt abscesses common
mucosa is friable & may have inflammatory pseudopolyps
TI may demonstrate inflammatory changes (backwash ileitis)
Schwartz 9th edition
www.downstatesurgery.org
Gross Pathology
Mild Colitis
Severe Colitis
www.downstatesurgery.org
Microscopic Pathologywww.downstatesurgery.org
Lead Pipe Colonwww.downstatesurgery.org
Symptoms Bloody diarrhea Abdominal cramping Tenesmus (proctitis) Fulminant colitis
Bloody diarrhea, severe abd pain, dehydration, high fever
Schwartz 9th edition
www.downstatesurgery.org
Diagnosis
Colonoscopy
Mucosal biopsy
Schwartz 9th edition
www.downstatesurgery.org
Endoscopy Mild
Moderate
Severe
www.downstatesurgery.org
Indications for Emergent Surgery
Life threatening hemorrhage (1%) Toxic megacolon (2.5%) Fulminant colitis (15%)*pts who fail to respond to medical therapy*deterioration or failure to improve w/in 24-
48hrs Acute perforation Obstruction due to stricture (11%) Abdominal colectomy w/ ileostomy
Schwartz 9th ed, Maingot 11th ed
www.downstatesurgery.org
Intractability despite maximal medical
therapy
High risk of complications from medical
therapy
Significant risk of developing colorectal Ca
Indications for Elective Surgery
Schwartz 9th ed, Maingot 11th ed
www.downstatesurgery.org
Risk for Colorectal Ca Increased w/ early age at Dx, increased
duration, extent of Dz
Increased w/ duration
2% after 10yrs & increases 0.5-1% annually
afterward
8% after 20yrs
18% after 30yrs
Schwartz 9th edition, Maingot 11th ed, Cameron 10th ed
www.downstatesurgery.org
More likely to arise from areas of flat dysplasia making early Dx more difficult
=> pts undergo (40-50) random Bx during colonoscopy
Annual surveillance after 8yrs for pts w/ pancolitis, 15 yrs for pts w/ L. colitis
Ca may be present in up to 20% of pts w/ low grade dysplasia
Risk for Colorectal Ca
Schwartz 9th edition, Maingot 11th ed, Cameron 10th ed
www.downstatesurgery.org
Proctocolectomy & Ileostomy
Single stage
Curative
Incontinent
Use of collecting device
20% morbidity:
Hemorrhage, sepsis, neural injuryMaingot 11th ed
www.downstatesurgery.org
Subtotal Colectomy & Ileal-rectal Anastomosis No need for stoma
Pelvic autonomic nerves are undisturbed
Not curative, 20% proctectomy
Contraindicated in pts w/
Anal sphincter dysfunction, severe rectal Dz,
rectal dysplasia, or malignancyMaingot 11th ed
www.downstatesurgery.org
Continent Ileostomy/ Koch Pouchwww.downstatesurgery.org
Continent Ileostomy/ Koch Pouch
45-50cm of terminal ileum is used
The proximal 30-35cm is fashioned into a pouch
The outflow tract is intussuscepted & sutured/stapled
creating a nipple valve
The reservoir is sutured to the peritoneum & fascia
The efferent limb is externalized as a flush stoma
Passing a soft plastic tube through the nipple valve
empties the pouchMaingot 11th ed
www.downstatesurgery.org
Offered a curative resection and continence
Complicated by Nipple valve failure requiring revision 60%
Enteritis, pouchitis, nonspecific ileitis
Fat & B12 malabsorption
Neural and perineal wound problems similar to that of standard proctocolectomy
Still 2/3 are satisfied after 30 yrs
Continent Ileostomy/ Koch Pouch
Maingot 11th ed, Lepisto et al 2003
www.downstatesurgery.org
Total Proctocolectomy w/ Ileal Pouch-Anal Anastomosis
End to end ileal-anal anastomosis at the dentate line
Benefits Preserve parasympathetics
Preservation of the anorectal sphincter
Elimination of the perineal proctectomy
Permanent ileostomy not required, maintains continence
High stool frequency
Diverting loop ileostomyMaingot 11th ed
www.downstatesurgery.org
R/O Crohn’s or other pathology preop
Colonoscopy & biopsy
UGI series
Intraoperative palpation of SB
Total Proctocolectomy w/ Ileal Pouch-Anal Anastomosis
www.downstatesurgery.org
Operative Technique of IPAA
Lithotomy
Midline incision
Colon mobilization
Transect ileum ~1-2cm proximal to ICV
Ileocolic A & colonic mesentery serially clamped, divided, & ligated
Rectal mobilization to the levator ani sling
Transect rectum 1-2cm above dentate line
Maingot 11th ed
www.downstatesurgery.org
Ileal Pouch Construction
A. J-pouch, B. S-pouch, C. Side-to-side isoperistaltic pouch, and D. W-pouch
www.downstatesurgery.org
Ileal J-Pouch
www.downstatesurgery.org
Ileal J-Pouch 15-20cm of the stapled off TI is folded onto itself in the
shape of a J
The distal/efferent limb is secured to the afferent limb
The pouch is formed using sequential firings of a 75-mm
mechanical stapler applied through an enterotomy in the
apex of the pouch
Pouch is filled w saline to check staple line (should hold 2-
300cc)
Mobilize the SB mesentery so the pouch can reach the pelvis
w/ no tensionMaingot 11th ed
www.downstatesurgery.org
Hand Sewn Ileal-anal Anastomosiswww.downstatesurgery.org
Double-Staple
Ileal-anal Anastomosis
www.downstatesurgery.org
Mucosectomy vs Double Staple
Double Staple = retained rectal mucosa => potential for proctitis & Ca
Double staple Increased anal resting pressure
Preservation of the rectoanal inhibitory reflex
Improved continence
Fewer septic complications
Other studies have shown no difference
=> surgeon’s preferenceMaingot 11th ed, Hallgren et al 1995
www.downstatesurgery.org
Salient Points Pathophysiology still poorly understood Emergent surgery
Hemorrhage, Toxic megacolon, Fulminant colitis, Perforation, Obstruction
Subtotal colectomy w/ ileostomy
Elective surgery Intractability of symptoms, complications from
medications, risk of Ca Total proctocolectomy w/ IPAA
Total proctocolectomy w/ Ileal J pouch AA R/O other pathology preoperatively Provides curative surgery w/ continence
www.downstatesurgery.org
References Schwartz’s Principles of Surgery, 9th Edition 2010 Current Surgical Therapy, 9th Edition Cameron 2008 Maingot’s Abdominal Operations, 11th Edition 2007 Liu L, Markus I, Saghire HE, et al. Distinct differences in tachykinin gene expression in
ulcerative colitis, Crohn’s disease, and diverticular disease: a role for hemokinin-1? Neurogastroenterology Motility. no. doi: 10.1111/j.1365-2982.2011.01685.x
Larson DW, Pemberton JH. Current concepts and controversies in surgery for IBD. Gastroenterology 2004;126:1611–1619
Cheung O, Regueiro MD. Inflammatory bowel disease emergencies. Gastroenterol Clin North Am 2003;32:1269–1288 Lepisto AH, Jarvinen HJ. Durability of Kock continent ileostomy. Dis Colon Rectum 2003;46:925–928
Lepisto AH, Jarvinen HJ. Durability of Kock continent ileostomy. Dis Colon Rectum2003;46:925–928
Borjesson L, Oresland T, Hulten L. The failed pelvic pouch: conversion to a continent ileostomy. Tech Coloproctol 2004;8:102–105
Heppell J, Kelly KA, Phillips SF et al. Physiologic aspects of continence after colectomy, mucosal proctectomy, and endorectal ileal-anal anastomosis. Ann Surg 1982;195:435–443
Parks AG, Nicholls RJ. Proctocolectomy without ileostomy for ulcerative colitis. BMJ1978;2:85–88
Utsunomiya J, Iwama T, Imajo M et al. Total colectomy, mucosal proctectomy, and ileal-anal anastomosis. Dis Colon Rectum 1980;23:459–466
Taylor BM, Cranley B, Kelly KA et al. A clinico-physiological comparison of ileal pouch-anal and straight ileoanal anastomoses. Ann Surg 1983;198:462–468
Hallgren TA, Fasth SB, Oresland TO, Hulten LA. Ileal pouch anal function after endoanal mucosectomy and hand sewn ileoanal anastomosis compared with stapled anastomosis without mucosectomy. Eur J Surg. 1995 Dec; 161(12):915-21
Farouk R, Pemberton JH, Wolff BG et al. Functional outcomes after ileal pouch-anal anastomosis for chronic ulcerative colitis. Ann Surg 2000;231:919–926
www.downstatesurgery.org
Medical Management - Salicylates
Sulfasalazine Inhibition of cyclooxygenase & 5-lipoxygenase in gut
mucosa & => decrease inflammation Pentasa(mesalamine), asacol, rowasa, canasa remission 80% @3g/day Sulfapyradine attached to 5-ASA which is cleaved by
enteric bacteria inflammatory side effex Oral, topical, or combo Drug of choice for mild to moderate disease
www.downstatesurgery.org
Steroids Moderate to severe HTN, hyperglycemia, cataracts, osteoporosis,
osteomalacia Budesonide, beclomethasone undergo rapid
hepatic degradation to limit systemic toxicity
Medical Management
www.downstatesurgery.org
Medical Management Immunosuppressive Agents
Azathioprine, 6-MCP Interfere w/ nucleic acid synthesis Good for those who failed salicylate Tx or are dependent on
steroids (6-12 wk onset of axn) Cyclosporine
Interferes w/ T cell funxn Helps acute flares 80%
Methotrexate Folate antagonist
Infliximab (Remicade) Monoclonal Ab against TNF alpha >50% w/ moderate to severe Dz respond
www.downstatesurgery.org
Extraintestinal Manifestations
Liver most common: fatty liver 40-50% reverse by med or Sx, cirrhosis (2-5%) irreversible
Primary sclerosing cholangitis strixrs of intra & extrahepatic ducts (40-60% have UC) only effective therapy is liver transplant
Cholangiocarcinoma rare but pts r ~20yrs younger than typical pts w/ it
Arthritis improves w/ meds or Sx but sacroiliitis or ankylosing spondylitis does not
Erythema nodosum 5-15%, W:M 3-4:1, raised red & on lower legs & pyoderma grangenosum some may improve w/ Sx
www.downstatesurgery.org
Post-IPAA
Barium enema & flex sig Evaluate anal sphincter tone Loop ileostomy reversed
www.downstatesurgery.org